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Abstract	
Purple	mangosteen	and	apple	are	the	two	most	popular	fruits	in	Indonesia,	but	very	
few	consume	the	peel,	which	is	arguably	the	healthiest	part	of	the	whole	fruit.	Both	purple	
mangosteen	 and	 apple	 peels	 are	 rich	 in	 antioxidants,	 which	 contribute	many	 of	 their	
health	benefits.	People	generally	use	the	peels	for	many	purposes,	either	medical	or	non‐
medical,	by	brewing,	boiling,	and	juicing.	To	make	the	peels	easier	to	take,	the	formulation	
of	 effervescent	 tablet	 is	 needed.	 This	 research	 aimed	 to	 get	 the	 optimum	effervescent	
tablet	formula	of	purple	mangosteen	and	apple	peel	extract,	which	fulfils	the	requirement	
of	 standard	 effervescent	 tablet	 and	physical	 evaluation.	 The	 extraction	method	 in	 this	
research	 is	 maceration,	 which	 used	 ethanol	 70%	 as	 the	 solvent.	 The	 process	 of	 this	
effervescent	tablet	used	a	wet	granulation	that	optimizes	various	formulas	to	get	the	best	
one.	The	analysis	of	physical	effervescent	tablet	properties	used	theoretical	approach.	The	
result	 of	 this	 study	 concluded	 that	 the	 best	 effervescent	 tablet	 formula	 of	 purple	
mangosteen	and	apple	peel	extract	contained	citric	acid,	tartaric	acid,	sodium	bicarbonate	
with	 the	 ratio	 of	 1:2:3.	Meanwhile,	 the	 results	 of	 physical	 evaluation	 showed	 that	 the	
content	 uniformity	 of	 the	 effervescent	 tablets	was	 3.050	 gram,	 the	 hardness	 test	was	
6.489	kg/cm2,	the	friability	test	was	0.05%,	and	the	solubility	test	was	1.73	minutes.	
	
Keywords	
Purple	mangosteen;	apple;	effervescent;	tablet;	formulation	
	
 
1. Introduction	
Purple	mangosteen	(Garcinia	mangostana	L.)	is	a	functional	plant,	since	most	parts	
of	it	can	be	used	for	both	medicinal	and	non‐medicinal	purposes.	The	peel	of	it,	which	is	
usually	 discarded	 as	 a	 waste,	 has	 a	 number	 of	 essential	 health	 benefits.	 It	 is	 rich	 in	
antioxidants,	including	anthocyanins	and	xanthones	(Moongkarndi	et	al.,	2004).		
Apple	(Pyrus	mallus	L)	is	a	fruit	that	is	rich	in	various	phytochemical	substances;	
one	of	them	is	flavonoids	(Boyer	et	al.,	2004).	Other	studies	had	confirmed	that	the	peel	
of	apple	has	a	higher	antioxidant	property	than	its	flesh.	(Simamora,	2009).	
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People	have	traditionally	used	purple	mangosteen	peel	by	steeping	and	bringing	to	
a	 boil,	 while	 apple	 peel	 is	 by	 juicing.	 The	 proper	 formulation	 in	 processing	 natural	
ingredients	into	a	simple	preparation	easily	accepted	by	society	is	expected	to	improve	
the	practicality	and	interest	in	using	natural	medicine.		
One	of	the	efforts	to	improve	them	is	to	formulate	these	natural	ingredients	into	
effervescent	tablets.	Some	of	main	advantages	of	effervescent	tablets	is	that	it	is	easy	to	
prepare	and	does	contain	the	proper	dose.	Effervescent	tablets	also	produce	a	good	taste,	
since	their	carbonates	help	improve	the	taste	of	certain	drugs	(Lachman	et	al.,	1994).		
The	main	 purposes	 of	 this	 study	 were	 to	 formulate	 the	 peel	 extracts	 of	 purple	
mangosteen	and	apple	into	effervescent	tablet	and	to	test	their	physical	properties.	
2. Methods	
	
2.1. Materials	
Materials	used	in	this	study	came	in	two	types,	namely	active	and	additive.	Active	
ingredients	were	peel	extracts	of	purple	mangosteen	and	apple,	while	additives	included	
tartaric	 acid,	 citric	 acid,	 sodium	 bicarbonate,	 mannitol,	 aspartame,	 PVP,	 magnesium	
stearate,	and	lactose.		
2.2. Tools	
	
Some	tools	used	in	this	study	included	rotary	evaporator	(IKA®),	some	glass	tools	
(Pyrex®),	some	containers	for	granulation,	mortar	and	stamper,	type	GT/GTB	granulate	
flow	tester	(Erweka®),	digital	stopwatch,	hardness	tester	(Stokes	Monsanto®),	friability	
tester	 (TA‐	 10/TA‐20),	 moisture	 balance	 MB45	 (Ohaus®),	 analytical	 scales	 AR2140	
(Ohaus®),	 oven	 (Memmert	 drying	 oven),	 sieves	 no.	 14	 and	 20	 type	AT‐340	 (Indotest	
Multi	Laboratama®),	and	single	punch	tablet	press	(Korsch®).	
	
3. Procedures	
	
3.1. Extraction	
Powdered	peels	were	extracted	with	a	maceration	method	using	70%	ethanol.	 It	
was	done	by	immersing	the	peels	into	70%	ethanol	for	5	days	and	stirring	every	day	for	
the	perfect	results.	After	5	days,	the	extracted	peels	were	filtered	and	re‐macerated	for	2	
days	to	optimize	them.	The	macerated	extracts	were	entirely	evaporated	using	a	rotary	
evaporator	to	obtain	thickened	extracts,	then	weighed	with	an	analytical	scale.	
3.2. Granule	Preparation	
Preparing	effervescent	granules	of	purple	mangosteen	and	apple	peel	extracts	was	
done	 by	 weighing	 thick	 extracts	 mixed	 with	 lactose	 and	 then	 preparing	mass	 of	 wet	
granules	using	PVP	by	sieving	the	ingredients	with	sieve	no.	14	and	then	drying	them	with	
a	temperature	of	about	40‐60°C	for	24	hours.	After	dried,	granules	were	re‐sieved	with	a	
sieve	no.	20.	The	mixture	was	put	into	an	oven	at	50°C	for	an	hour,	so	it	will	be	melted.	
Dried	granules	obtained	were	sieved	with	sieve	no.	20.	
 
3.3. Formulation	
Effervescent	 tablets	of	purple	mangosteen	and	apple	peel	extracts	were	made	 in	
one	 formula	 (Formula	 I),	 but	 after	 evaluation	 of	 granule,	 physical,	 and	 organoleptic	
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properties,	they	did	not	meet	the	standard	requirement.	So,	they	should	be	optimized.	The	
results	of	the	formula	I	optimization	were	formula	II	and	formula	III.	
Table	 I	 is	a	reference	 formula	that	had	been	researched	by	Hidayati	(2007).	The	
formula	 contained	 extracts,	 lactose,	 citric	 acid,	 tartaric	 acid,	 potassium	 bicarbonate,	
magnesium	stearate,	aspartame,	and	PVP.	In	this	study,	there	are	some	differences	and	
changes	 of	 the	 formula,	 namely	 adding	 additives,	 such	 as	 sodium	 bicarbonate	 and	
mannitol.	Sodium	bicarbonate	is	a	frequently‐used	alkali	(base)	source,	while	mannitol	
provides	a	cooling	sensation	in	the	mouth	(Rowe	et	al.,	2006).	
Table	1.	Formulation	of	effervescent	tablet	
Ingredients	 Functions Formula	I	(%)	
Purple	mangosteen	and	apple	peel	extracts Active	ingredient 4
Lactose	 Filler 29.43	
Aspartame	 Sweetener 1.67	
Citric	acid	 Acid	source 15
Granule	extra	 Crusher 0.3
Sodium	bicarbonate	 Base	source 30
Granule	extra	 Crusher 0.6
Magnesium	stearate	 Lubricant 0.9
Mannitol	 Sweetener 1.67	
PVP	 Binder 0.02	
 
 
3.4. Effervescent	Tablet	Preparation	
Effervescent	granules	obtained	were	pressed	with	a	single	punch	tablet	machine.	
Both	tablets	and	all	tablet	tests	were	done	with	relative	humidity	of	45‐50%.	The	weight	
of	each	tablet	that	will	be	created	was	3000	milligrams.	
4. Result	and	Discussion	
 
4.1.	Extract	preparation	
The	extraction	method	used	in	this	study	was	maceration.	The	solvent	used	in	this	
maceration	was	70%	ethanol.	The	yield	of	the	resulting	purple	mangosteen	peel	extract	
was	11.11%,	while	apple	was	20.45%.	It	showed	that	there	were	polar	compounds	in	the	
peel	of	purple	mangosteen	(Garcinia	mangostana	L)	and	apple	(Pyrus	mallus	L).	It	means	
that	these	compounds	are	soluble	in	ethanol.	The	extraction	used	70%	ethanol	because	
desired	 thickened	extracts	had	polar	properties.	The	 terms	of	 ingredients	used	 in	 this	
study	were	water	soluble,	so	polar	thickened	extracts	will	be	easily	dissolved.	
 
4.2.	Optimization	and	Scale	Up	
The	 effervescent	 tablet	 optimization	 used	 in	 this	 study	was	 a	 formula	 design	 as	
presented	on	the	table	2.	This	optimization	was	done	in	the	preparation	and	formula	of	
the	effervescent	tablets.	Unfortunately,	the	physical	parameters	of	the	formula	I	were	less	
good,	so	the	formula	needs	to	be	optimized.	
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Table	2.	Optimized	formula	of	effervescent	tablets	
Based	on	the	Table	2	above,	the	formula	I	was	a	basic	formula.	The	preparation	of	
this	formula	was	done	using	a	wet	granulation	method	without	a	phase	separation.	The	
formula	 I	 produced	 tablets	 that	 did	 not	 meet	 the	 standard	 requirements	 of	 good	
manufacturing	effervescent	tablets	(Table	3).	
Table	3.	The	result	of	effervescent	tablet	physical	test	
F	 Weight	Uniformity	(mg) Friability	
(%)	
Hardness	
(kg/cm3)	
Dissolve	Time	
(minutes)	A	(5%)	 B	(10%)
F1	 3.038	±	0.152	 3.038	±	0.304 2.12 4.21 3.36	
F2	 3.045	±	0.152	 3.045	±	0.303 0.06 7.453 24.48	
F3	 3.050	±	0.153	 3.050	±	0.305 0.05 5.496 1.73	
Scale	Up	 3.073	±	0.154	 3.073	±	0.307 0.31 6.489 1.83	
 
The	formula	II	was	obtained	after	optimizing	formula	I.	This	second	formula	used	a	
wet	granulation	method	with	a	phase	separation.	Changes	in	this	method	were	done	to	
avoid	any	undesired	reaction	of	the	effervescent.	In	formula	II,	surfactants	tween	80	were	
added	into	the	formula	to	overcome	the	solubility	of	the	extracts.	The	formula	II	produced	
a	good	tablet.	However,	one	of	the	physical	parameters	of	this	formula,	which	did	not	meet	
the	 requirement,	was	 the	dissolve	 time.	Based	on	 this	evaluation,	 further	optimization	
needs	to	be	done	to	obtain	a	qualified	formula.	
Optimization	of	the	formula	III	was	done	by	changing	the	concentration	of	the	acid	
and	alkaline	source.	It	contained	more	sodium	bicarbonate	compared	to	formula	I	and	II.	
The	formulation	changes	aimed	to	improve	dissolve	time	of	the	effervescent	tablets.	The	
result	showed	that	formula	III	met	all	the	requirements,	so	a	scale	up	could	be	done.	
Based	on	Table	3,	formula	I	tablets	produced	a	weight	uniformity	that	met	all	the	
requirements	 of	 the	 4th	 Indonesian	 Pharmacopoeia,	 i.e.	 there	 are	 no	 two	 tablets	 that	
deviate	more	than	5%	of	average	weight	and	no	one	tablet	that	deviate	more	than	10%	of	
Ingredients	 Formula	(%)	I	 II	 III	
Purple	mangosteen	and	apple	peel	extracts	 4	 4	 4	
Lactose	 29.43	 26.1	 16.76	
Aspartame	 1.67	 2.6	 2.6	
Citric	acid	 15	 15	 11.57	
Granule	extra	 0.3	 0.3	 0.3	
Tartaric	acid	 15	 15	 23.1	
Granule	extra	 0.3	 0.3	 0.3	
Sodium	bicarbonate	 30	 30	 34.67	
Granule	extra	 0.6	 0.6	 0.6	
Magnesium	Stearate	 0.9	 0.9	 0.9	
Mannitol	 1.67	 5.6	 5.6	
PVP	 0.2	 0.167	 0.015	
Tween	80	 0	 0.017	 0.017	
NOTE:	      
Formula	1:	Tablet	preparation	with	wet	granulation	without	phase	separation.	
Formula	2:	Tablet	preparation	with	wet	granulation	with	phase	separation.	
Formula	3:	Tablet	preparation	with	wet	granulation	with	phase	separation.
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average	weight.	The	results	of	weight	uniformity	of	effervescent	tablets	had	a	good	CV	
value,	which	was	 less	 than	6%,	so	all	 the	 formulas	had	a	good	weight	uniformity.	The	
weight	uniformity	test	showed	that	formula	I	produced	a	good	weight	uniformity,	since	it	
had	the	lowest	CV	value	(1.119%)	compared	to	other	formulas.	It	might	be	due	to	the	flow	
time	of	formula	I	that	was	better	than	the	others	(Table	1).	
In	 addition	 to	 a	 good	weight	 uniformity,	 formula	 I	 produced	 the	 value	 of	 tablet	
hardness	(4.21	kg/cm2),	 friability	(2.12%),	and	dissolve	time	(3.36	minutes).	Hardness	
test	showed	that	formula	I	had	the	lowest	value.	The	difference	of	such	hardness	was	due	
to	 an	 uneven	 distribution	 of	 liquid	 binder	 in	 all	 parts	 of	 the	 granules.	 Liquid	 binder	
produced	a	liquid	bridge,	which	naturally	occurred	when	drying	wet	granules	and	would	
turn	into	a	solid	bridge	in	the	granules	due	to	liquid	binder	that	would	remain	behind,	did	
not	evaporate,	and	would	glue	granule	particles,	so	that	the	tablet	becomes	harder.	
The	compression	will	cause	granules	went	into	a	plastic	deformation,	so	it	became	
a	 compact	mass,	 namely	 into	 tablet	 form.	The	 effervescent	 tablet	 hardness	 affects	 the	
resistance	of	tablet	against	mechanical	disturbances.	Compact	or	hard	tablets	were	not	
easily	destroyed	during	distribution	and	storage	(Ansar,	2009).	
Besides	low	hardness	value,	formula	I	had	a	high	friability.	Friability	describes	the	
strength	of	tablet	surface	in	resisting	treatments	causing	abrasion	of	the	tablet	surface.	
Friability	is	strongly	influenced	by	tablet	hardness.	
The	friability	value	of	formula	I	was	2.12%.	It	was	the	highest	value	among	other	
formulas.	The	differences	of	friability	value	were	probably	caused	by	differences	in	the	
concentration	of	PVP	as	a	wetting‐granule	agent.	The	concentrations	used	in	Formula	I	as	
a	 granulating	 agent	 was	 5%,	 while	 in	 other	 formulas	 was	 10%.	 The	 concentration	
differences	might	affect	granule	wetting	process.	In	addition,	it	could	be	caused	by	low	
hardness	value	and	bonding	among	particles	at	the	surface	of	the	tablet.	The	greater	the	
percentage	 of	 fragility,	 the	more	mass	will	 be	 lost.	 Loss	 of	 tablet	mass	will	 affect	 the	
amount	of	active	ingredients.	
Another	 characteristic	 of	 effervescent	 tablets,	 in	 addition	 to	 weight	 uniformity,	
hardness,	and	friability,	is	dissolve	time.	It	represents	the	time	required	by	the	tablet	to	
be	completely	 soluble	 in	a	certain	volume	of	water.	The	 results	of	 the	 formula	 I	had	a	
dissolve	 time	 that	 did	 not	 meet	 the	 standard	 requirement	 (3.36	 minutes).	 According	
Mohrle	(1980),	a	good	dissolve	time	ranges	from	1	‐	2	minutes.	
After	describing	formula	I,	it	was	obtained	a	number	of	deficiencies	that	should	be	
corrected,	so	optimization	was	needed	to	produce	better	 formulas.	Formula	II	was	the	
result	of	the	formula	I	optimization.	In	formula	II,	there	were	some	modifications	in	the	
concentration	and	the	additive	ingredients.	Unlike	previous	formula,	the	formula	II	used	
wet	granulation	method	with	a	phase	separation.	The	changes	were	made	to	avoid	early	
undesired	effervescent	reaction	(Lestari,	2007).	
Evaluation	of	weight	uniformity	in	the	formula	II	produced	uniform	tablets	with	CV	
value	 less	 than	6%	(1.29%),	hardness	 (7.453	kg/cm2),	 friability	 (0.06%),	 and	dissolve	
time	(24.48	minutes).	The	hardness	value	of	the	formula	II	was	the	highest.	It	could	be	
due	 to	 some	 solid	 bridges	 that	 were	 formed,	 thereby	 increasing	 the	 tablet	 hardness.	
Meanwhile,	 dissolve	 time	 of	 the	 formula	 II	was	 the	 longest.	 It	was	 due	 to	 the	 storage	
process	of	effervescent	tablets	in	the	room	that	has	a	fairly	high	relative	humidity	(45	to	
50%),	 thus	 causing	 the	 reaction	 of	 CO2	 with	 water,	 resulting	 in	 reduced	 power	
carbonation	when	dissolved	in	the	water	thus	making	dissolve	time	longer.	
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Physical	evaluation	of	formula	III	effervescent	tablets	showed	that	they	had	good	
weight	uniformity,	their	CV	value	was	the	highest	(1.887%).	Fortunately,	this	value	was	
still	less	than	6%,	so	it	was	still	allowed.	Formula	III	had	a	high	CV	value	because	its	flow	
time	was	fairly	long	(17	gram/second).	Smaller	flow	time	of	the	granules	would	support	
the	uniformity	of	mold‐filling	(die)	by	the	granules	and	affect	the	weight	uniformity	of	the	
tablet.	 A	 perfect	 flow	 time	 will	 produce	 good	 form	 and	 weight	 uniformity	 tablets	
(Lachman,	1989).		
The	percentage	of	friability,	hardness,	and	dissolve	time	of	the	formula	III	did	meet	
all	the	standard	requirements.	The	dissolve	time	of	the	formula	III	was	different	from	both	
formula	I	and	II.	The	formula	III	had	a	dissolve	time,	which	was	less	than	2	minutes	(1.73	
minutes).	It	could	be	due	to	the	differences	of	the	crushing	agent	(sodium	bicarbonate)	
concentration.	 High	 concentrations	 of	 sodium	 bicarbonate	 affect	 the	 solubility	 of	
effervescent	 tablets.	 It	 occurs	 because	 sodium	bicarbonate	 serves	 as	 a	 crushing	 agent	
when	it	reacts	with	water	and	will	produce	CO2	gas,	thereby	providing	a	refreshing	effect	
(Ansar,	2009).	
The	 formula	 III,	 in	 addition	 to	having	 a	 good	weight	uniformity	value,	produced	
effervescent	tablets	that	did	not	taste	bitter,	had	a	good	extract	solubility,	3	cm	foaming,	
and	 a	 good	 aroma.	 Aroma	 contained	 in	 the	 effervescent	 tablets	was	 derived	 from	 the	
purple	mangosteen	peel	extract	combined	with	apple	peel	extract	and	acidic	materials	
used	as	raw	materials	of	effervescent	tablets.		
The	optimization	of	effervescent	 tablets	produced	 formula	 III,	which	had	a	good	
granular	and	physical	evaluation	value	and	met	the	standard	requirements.	Formula	III	
was	an	optimum	formula,	so	it	was	scaled	up	to	100	tablets.	A	100	tablet	scale	up	process	
produced	 granular	 and	 physical	 evaluation	 values	 that	 entirely	 met	 the	 standard	
requirements.	
5. Conclusion	
 
The	effervescent	tablet	formulation	of	purple	mangosteen	(Garcinia	mangostana	L)	
and	apple	(Pyrus	mallus	L)	peel	extracts	that	met	all	standard	requirements	was	formula	
III.	The	formula	contained	citric	acids,	tartaric	acids,	sodium	bicarbonate	in	the	ratio	of	1:	
2:	 3	 and	 filling	 (lactose),	 binding	 (PVP),	 lubricating	 (magnesium	 stearate)	 agent,	 and	
combination	 of	 sweeteners,	 i.e.	 aspartame	 and	 mannitol.	 The	 results	 of	 the	 physical	
evaluation	 of	 the	 formula	 III	 were	 as	 follows:	 the	 average	 weight	 (3.050	 ±	 0.153),	
hardness	 (6,489	 kg/cm2),	 friability	 (0.05%),	 and	 dissolve	 time	 (1.73	 minutes).	 All	
physical	 evaluation	 results	of	 the	 formula	 III	had	met	 the	 standard	 tablet	effervescent	
requirements.	
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